Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: microbiome

Anatomy Insider / shutterstock.com

Gut Instinct: Ankylosing Spondylitis & the Microbiome

Jason Liebowitz, MD, FACR  |  October 3, 2019

CHICAGO—At the 2019 ACR State-of-the-Art Clinical Symposium, an annual gathering featuring talks by key opinion leaders on the most salient topics for practicing rheumatologists and healthcare providers, Jose U. Scher, MD, director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Medical Center, New York City, was the featured speaker. In his remarks,…

Filed under:Axial SpondyloarthritisConditions Tagged with:Ankylosing Spondylitisgut microbiomeMicrobiome

Probing the Role of Genes & Microbiome in Ankylosing Spondylitis & RA

Lara C. Pullen, PhD  |  September 17, 2019

Researchers know human leukocyte antigen (HLA) molecules affect susceptibility to disease in general, and immunological disease in particular. In the case of ankylosing spondylitis (AS), the risk is primarily associated with HLA-B27, with smaller effects from other HLA alleles. Current thinking is that AS is caused by the presence of a genetically primed host because…

Filed under:Axial SpondyloarthritisConditionsResearch RheumRheumatoid Arthritis Tagged with:Ankylosing SpondylitisGenesgut microbiome

The Microbiome: A Predictor of Autoimmune Response?

Thomas R. Collins  |  July 18, 2019

CHICAGO—The world of rheumatology is beginning to harness the promise of the microbiome, with evidence showing components of the gut may help predict response to medication and may be manipulated to improve how well a treatment works, said Jose Scher, MD, at the 2019 ACR State-of-the-Art Clinical Symposium, held April 5–7. “We can truly exploit…

Filed under:ConditionsResearch Rheum Tagged with:MicrobiomePrecision MedicinepredictorResearch

Mouse Research Suggests the Microbiome Is Related to Lupus

Kurt Ullman  |  July 18, 2019

Research in type I interferon (IFN) driven mouse models of systemic lupus erythematosus (SLE) suggests the microbiome may play a role in the development of autoimmunity. Additionally, changes in diet may induce protective effects in the gut.1 “Microbes in the gut worsen a lupus model related to the interferon pathway,” says Martin A. Kriegel, MD,…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:interferonmiceMicrobiomemouse modelResearch

The Microbiome: A Predictor of Response?

Natasha Yetman  |  June 12, 2019

New research by Jose Scher, MD, discussed during the 2019 ACR State-of-the-Art Clinical Symposium, demonstrated how clinicians may be able to modify aspects of the microbiome to predict and boost a patient’s treatment response…

Filed under:Uncategorized Tagged with:2019 State-of-the-Art Clinical Symposiumdrug treatmentMicrobiomePharmacomicrobiomics

Studies Find More Evidence the Microbiome Affects Autoimmune Disease

Kurt Ullman  |  August 17, 2018

Evidence is accumulating that the microbiome may be an important part of the pathogenesis of many autoimmune diseases. Two recently published articles report on how translocation of the gut bacterium Enterococcus gallinarum drives autoimmunity in mice and humans, and on the role of other commensal bacteria in triggering immune responses—specifically to the autoantigen Ro60, which…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:gut microbiomeMicrobiome

Alterations in the Microbiome Are Associated with Changes in Bone Quality

Lara C. Pullen, PhD  |  March 28, 2017

By treating mice with antibiotics, researchers found that alterations in the gut microbiome impaired the mechanical properties of bone and depleted splenic B and T cell populations. The researchers suspect the decrease in bone strength resulted from the change in the immune system…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bonebone mineral density (BMD)gut microbiomeMicrobiomeOsteoporosis

Volatility of the Gut Microbiome Tied to IBD

Marilynn Larkin  |  February 21, 2017

NEW YORK (Reuters Health)—Fluctuations in the gut microbiome over time could underlie inflammatory bowel disease (IBD), including Crohn’s and ulcerative colitis, researchers suggest. “Both the state and the dynamics of the human gut microbiome in healthy individuals are highly personalized. Although cross-sectional studies have revealed dysbiosis of the gut microbiome in IBD, little is known…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Crohn's diseasegut microbiomeMicrobiomeulcerative colitis

Dysbiosis of Gut, But Not Ocular Microbiome, Associated with Sjögren’s Syndrome

Lara C. Pullen, PhD  |  July 11, 2016

Research has explored the connection between Sjögren’s syndrome and intestinal dysbiosis associated with ocular mucosal disease. A recent study found that oral antibiotics and desiccating stress lead to extreme changes in the gut microbiota in mice. In patients with Sjögren’s syndrome, researchers found that patients with the most severe keratoconjunctivitis sicca and combined systemic and ocular disease had the lowest diversity of stool microbiota…

Filed under:ConditionsOther Rheumatic ConditionsSjögren’s Disease Tagged with:antibioticseyegut microbiomeMicrobiomeSjogren's

The Gut Microbiome Influences Postmenopausal Bone Loss

Lara C. Pullen, PhD  |  June 27, 2016

Bone health has been successfully improved by using probiotics to influence the gut microbiome in postmenopausal women with osteoporosis. New research has gained insight into this process, uncovering that sex steroid depletion increases gut permeability resulting in inflammation and pathology in mice. Treatment with probiotics also prevents this increase in gut permeability and bone loss associated with sex steroid depletion…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bonebone lossgut microbiomeMicrobiomeOsteoporosispostmenopauseWomen

  • 1
  • 2
  • 3
  • …
  • 13
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences